Perianal Crohn's disease: Is there something new?

World Journal of Gastroenterology

Volumn 17, Issue 15, 2011, Pages 1939-1946

  Ruffolo, Cesare ^a   Citton, Marilisa ^b   Scarpa, Marco ^c   Angriman, Imerio ^b   Massani, Marco ^a   Caratozzolo, Ezio ^a   Bassi, Nicolò ^a  

^a Regional Hospital C Foncello   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Biologic therapy; Crohn disease; Diagnosis; Rectal fstula; Surgery

Indexed keywords

ADALIMUMAB; AST 120; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TACROLIMUS; THALIDOMIDE;

ANUS DISEASE; ARTICLE; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DRUG DOSE INCREASE; HUMAN; INFECTION; LUPUS ERYTHEMATOSUS; PATHOGENESIS; QUALITY OF LIFE; SURGEON; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 79955936808     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i15.1939     Document Type: Article

References (85)

1. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125: 1508-1530
2. Vermeire S, Van Assche G, Rutgeerts P. Perianal Crohn's disease: classifcation and clinical evaluation. Dig Liver Dis 2007; 39: 959-962
3. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-656
4. Lapidus A, Bernell O, Hellers G, Löfberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998; 114: 1151-1160
5. Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Peri-anal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008; 103: 3082-3093
6. Nielsen OH, Rogler G, Hahnloser D, Thomsen OO. Diagnosis and management of fstulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009; 6: 92-106
7. Ingle SB, Loftus EV Jr. The natural history of perianal Crohn's disease. Dig Liver Dis 2007; 39: 963-969
8. Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880
9. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and lu-minal fstulas associated in Crohn's disease? A population-based study. Clin Gastroenterol Hepatol 2006; 4: 1130-1134
10. Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fstulas in Crohn disease. Ann Intern Med 2001; 135: 906-918
11. Tozer PJ, Whelan K, Phillips RK, Hart AL. Etiology of perianal Crohn's disease: role of genetic, microbiological, and immunological factors. Inflamm Bowel Dis 2009; 15: 1591-1598
12. Ruffolo C, Scarpa M, Faggian D, Romanato G, De Pellegrin A, Filosa T, Prando D, Polese L, Scopelliti M, Pilon F, Ossi E, Frego M, D'Amico DF, Angriman I. Cytokine network in chronic perianal Crohn's disease and indeterminate colitis after colectomy. J Gastrointest Surg 2007; 11: 16-21
13. Ruffolo C, Scarpa M, Faggian D, Pozza A, Navaglia F, D'Incà R, Hoxha P, Romanato G, Polese L, Sturniolo GC, Plebani M, D'Amico DF, Angriman I. Cytokine network in rectal mucosa in perianal Crohn's disease: relations with inflammatory parameters and need for surgery. Inflamm Bowel Dis 2008; 14: 1406-1412
14. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sand-born WJ, Sutherland LR. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15
15. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classifcation of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753
16. Parks AG, Gordon PH, Hardcastle JD. A classification of fstulainano. Br J Surg 1976; 63: 1-12
17. Hughes LE. Surgical pathology and management of anorec-tal Crohn's disease. J R Soc Med 1978; 71: 644-651
18. Hughes LE. Clinical classifcation of perianal Crohn's disease. Dis Colon Rectum 1992; 35: 928-932
19. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995; 20: 27-32
20. Losco A, Viganò C, Conte D, Cesana BM, Basilisco G. Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound. Inflamm Bowel Dis 2009; 15: 742-749
21. Taxonera C, Schwartz DA, García-Olmo D. Emerging treatments for complex perianal fstula in Crohn's disease. World J Gastroenterol 2009; 15: 4263-4272
22. Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, Zinsmeister AR, Norton ID, Boardman LA, Devine RM, Wolff BG, Young-Fadok TM, Diehl NN, Pemberton JH, Sandborn WJ. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fstulas. Gastroenterology 2001; 121: 1064-1072
23. Ardizzone S, Maconi G, Cassinotti A, Massari A, Porro GB. Imaging of perianal Crohn's disease. Dig Liver Dis 2007; 39: 970-978
24. Halligan S, Stoker J. Imaging of fistula in ano. Radiology 2006; 239: 18-33
25. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Infiximab for the treatment of fstulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405
26. Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Tacrolimus for the treatment of fstulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125: 380-388
27. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83: 383-387
28. Solomon MJ, McLeod RS, O'Connor BI, Steinhart AH, Greenberg GR, Cohen Z. Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease. Can J Gastroenterol 1993; 7: 571-573
29. Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ. Ciprofoxacin or metronidazole for the treatment of perianal fstulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15: 17-24
30. Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1113-1120
31. West RL, van der Woude CJ, Hansen BE, Felt-Bersma RJ, van Tilburg AJ, Drapers JA, Kuipers EJ. Clinical and endosonographic effect of ciprofoxacin on the treatment of peri-anal fstulae in Crohn's disease with infiximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20: 1329-1336
32. Maeda Y, Ng SC, Durdey P, Burt C, Torkington J, Rao PK, Mayberry J, Moshkovska T, Stone CD, Carapeti E, Vaizey CJ. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg 2010; 97: 1340-1347
33. Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopu-rine or azathioprine. Aliment Pharmacol Ther 2001; 15: 1699-1708
34. Pearson DC, May GR, Fick GH, Sutherland LR. Azathio-prine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132-142
35. Sandborn W. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995; 1: 48-63
36. Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Tacrolimus for the treatment of fstu-las in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125: 380-388
37. Soon SY, Ansari A, Yaneza M, Raoof S, Hirst J, Sanderson JD. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 921-926
38. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. N Engl J Med 2005; 352: 2193-2201
39. Wenzl HH, Hinterleitner TA, Aichbichler BW, Fickert P, Pe-tritsch W. Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome. Aliment Pharmacol Ther 2004; 19: 427-434
40. Plamondon S, Ng SC, Kamm MA. Thalidomide in luminal and fstulizing Crohn's disease resistant to standard therapies. Aliment Pharmacol Ther 2007; 25: 557-567
41. Hinojosa J, Gomollón F, García S, Bastida G, Cabriada JL, Saro C, Ceballos D, Peñate M, Gassull MA. Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial. Aliment Pharmacol Ther 2007; 25: 409-418
42. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029-1035
43. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infix-imab maintenance therapy for fstulizing Crohn's disease. N Engl J Med 2004; 350: 876-885
44. Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Human anti-tumor necrosis factor monoclonal antibody (adalimum-ab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006; 130: 323-333; quiz 591
45. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF. Adalimumab induction therapy for Crohn disease previously treated with infiximab: a randomized trial. Ann Intern Med 2007; 146: 829-838
46. Schwartz DA, Rutgeerts P, Colombel JF, Sandborn WJ, Hanauer SB, Kent JD, Pollack PF. Induction, maintenance, and sustainability of the healing of draining fistulas in patients with Crohn's disease treated with adalimumab: results of the CHARM study. Am J Gastroenterol 2006; 101 (Suppl 9): 1177
47. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657
48. Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfeld R, Schreiber S. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007; 357: 228-238
49. Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OØ, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 2007; 357: 239-250
50. Ng SC, Plamondon S, Gupta A, Burling D, Swatton A, Vaizey CJ, Kamm MA. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fstulas. Am J Gastroenterol 2009; 104: 2973-2986
51. Theis VS, Rhodes JM. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2008; 27: 19-30
52. Fukuda Y, Takazoe M, Sugita A, Kosaka T, Kinjo F, Otani Y, Fujii H, Koganei K, Makiyama K, Nakamura T, Suda T, Yamamoto S, Ashida T, Majima A, Morita N, Murakami K, Oshitani N, Takahama K, Tochihara M, Tsujikawa T, Wata-nabe M. Oral spherical adsorptive carbon for the treatment of intractable anal fstulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2008; 103: 1721-1729
53. Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, Reinshagen M, Tsianos E, Herrlinger K, Oldenburg B, Bouhnik Y, Kiesslich R, Stange E, Travis S, Lindsay J. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101
54. Fichera A, Michelassi F. Surgical treatment of Crohn's disease. J Gastrointest Surg 2007; 11: 791-803
55. Williams JG, Farrands PA, Williams AB, Taylor BA, Lunniss PJ, Sagar PM, Varma JS, George BD. The treatment of anal fstula: ACPGBI position statement. Colorectal Dis 2007; 9 Suppl 4: 18-50
56. Sangwan YP, Schoetz DJ Jr, Murray JJ, Roberts PL, Coller JA. Perianal Crohn's disease. Results of local surgical treatment. Dis Colon Rectum 1996; 39: 529-535
57. Williams JG, Rothenberger DA, Nemer FD, Goldberg SM. Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment. Dis Colon Rectum 1991; 34: 378-384
58. van der Hagen SJ, Baeten CG, Soeters PB, Beets-Tan RG, Russel MG, van Gemert WG. Staged mucosal advancement flap for the treatment of complex anal fstulas: pretreatment with noncutting Setons and in case of recurrent multiple abscesses a diverting stoma. Colorectal Dis 2005; 7: 513-518
59. Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fstula. Br J Surg 2004; 91: 476-480
60. Hyman N. Endoanal advancement flap repair for complex anorectal fstulas. Am J Surg 1999; 178: 337-340
61. Joo JS, Weiss EG, Nogueras JJ, Wexner SD. Endorectal advancement flap in perianal Crohn's disease. Am Surg 1998; 64: 147-150
62. Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fstulas in Crohn's disease. Gut 1995; 37: 696-701
63. Mizrahi N, Wexner SD, Zmora O, Da Silva G, Efron J, Weiss EG, Vernava AM 3rd, Nogueras JJ. Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 2002; 45: 1616-1621
64. Edwards CM, George BD, Jewell DP, Warren BF, Mortensen NJ, Kettlewell MG. Role of a defunctioning stoma in the management of large bowel Crohn's disease. Br J Surg 2000; 87: 1063-1066
65. Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg 2000; 24: 1258-1262; discussion 1262-1263
66. Mueller MH, Geis M, Glatzle J, Kasparek M, Meile T, Jehle EC, Kreis ME, Zittel TT. Risk of fecal diversion in complicated perianal Crohn's disease. J Gastrointest Surg 2007; 11: 529-537
67. Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg 2005; 241: 796-801; discussion 801-802
68. Collie MH, Potter MA, Bartolo DC. Myocutaneous flaps promote perineal healing in inflammatory bowel disease. Br J Surg 2005; 92: 740-741
69. Schaden D, Schauer G, Haas F, Berger A. Myocutaneous flaps and proctocolectomy in severe perianal Crohn's disease--a single stage procedure. Int J Colorectal Dis 2007; 22: 1453-1457
70. Bell SW, Dehni N, Chaouat M, Lifante JC, Parc R, Tiret E. Primary rectus abdominis myocutaneous flap for repair of perineal and vaginal defects after extended abdominoperi-neal resection. Br J Surg 2005; 92: 482-486
71. Ardizzone S, Maconi G, Colombo E, Manzionna G, Bollani S, Bianchi Porro G. Perianal fstulae following infiximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 2004; 10: 91-96
72. Ruffolo C, Penninckx F, Van Assche G, Vermeire S, Rutgeerts P, Coremans G, D'Hoore A. Outcome of surgery for rectovaginal fstula due to Crohn's disease. Br J Surg 2009; 96: 1190-1195
73. Ruffolo C, Scarpa M, Bassi N, Angriman I. A systematic review on advancement flaps for rectovaginal fstula in Crohn' s disease: transrectal vs transvaginal approach. Colorectal Dis 2010; 12: 1183-1191
74. Moy J, Bodzin J. Carbon dioxide laser ablation of perianal fstulas in patients with Crohn's disease: experience with 27 patients. Am J Surg 2006; 191: 424-427
75. Hammond TM, Grahn MF, Lunniss PJ. Fibrin glue in the management of anal fstulae. Colorectal Dis 2004; 6: 308-319
76. Cirocchi R, Farinella E, La Mura F, Cattorini L, Rossetti B, Milani D, Ricci P, Covarelli P, Coccetta M, Noya G, Sciannameo F. Fibrin glue in the treatment of anal fstula: a systematic review. Ann Surg Innov Res 2009; 3: 12
77. Vaughan D, Drumm B. Treatment of fstulas with granulocyte colony-stimulating factor in a patient with Crohn's disease. N Engl J Med 1999; 340: 239-240
78. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fstula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48: 1416-1423
79. Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fstula: a phase II clinical trial. Dis Colon Rectum 2009; 52: 79-86
80. Johnson EK, Gaw JU, Armstrong DN. Effcacy of anal fstula plug vs. fibrin glue in closure of anorectal fstulas. Dis Colon Rectum 2006; 49: 371-376
81. El-Gazzaz GS, Zutshi M, Hull TL. Plugging away at the anal fistula: an exercise in futility? Gastroenterology 2008; 134: A862
82. Hart AL, Plamondon S, Kamm MA. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Inflamm Bowel Dis 2007; 13: 245-253
83. Poggioli G, Laureti S, Pierangeli F, Rizzello F, Ugolini F, Gionchetti P, Campieri M. Local injection of Infiximab for the treatment of perianal Crohn's disease. Dis Colon Rectum 2005; 48: 768-774
84. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Treatment of perianal fstulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol 2006; 41: 1064-1072
85. Poggioli G, Laureti S, Pierangeli F, Bazzi P, Coscia M, Gentilini L, Gionchetti P, Rizzello F. Local injection of adalimumab for perianal Crohn's disease: better than infiximab? Inflamm Bowel Dis 2010; 16: 1631